James Colony

Title: James Colony: Innovator in Biomolecule Labeling Technologies

Introduction

James Colony is an accomplished inventor based in Seattle, WA (US). He has made significant contributions to the field of biomolecule labeling, holding a total of 2 patents. His innovative work focuses on enhancing the efficiency and effectiveness of biomolecule labeling processes.

Latest Patents

One of James Colony's latest patents is centered around polyaminocarboxylate chelators, specifically the chelator IDAC-2. This patent describes a method for removing unbound labeling reagents from a composition that includes both bound and unbound labeling reagents. The process involves using a chelator-matrix conjugate that binds to the unbound labeling reagent, allowing for the effective scavenging of these reagents from a biomolecule labeling reaction mixture. The result is a labeled biomolecule that is essentially free of unbound labeling reagents. Additionally, the novel chelator IDAC-2 can be utilized for both labeling biomolecules and scavenging within the chelator-matrix conjugate.

Career Highlights

Throughout his career, James Colony has worked with various companies, including Per Immune Holdings, Inc. His expertise in biomolecule labeling technologies has positioned him as a key player in the field, contributing to advancements that benefit both research and practical applications.

Collaborations

James has collaborated with notable professionals in his field, including Ramaswamy Subramanian. These partnerships have fostered innovation and have led to the development of cutting-edge technologies in biomolecule labeling.

Conclusion

James Colony's work in the realm of biomolecule labeling, particularly through his patents and collaborations, showcases his dedication to advancing scientific research. His contributions continue to impact the field positively, paving the way for future innovations.